Trinity Biotech PLC (TRIB)
1.802
+0.12
(+7.27%)
USD |
NASDAQ |
May 03, 16:00
1.76
-0.04
(-2.34%)
After-Hours: 20:00
Trinity Biotech Free Cash Flow: -14.26M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -14.26M |
| September 30, 2023 | -12.92M |
| June 30, 2023 | -8.282M |
| March 31, 2023 | -7.037M |
| December 31, 2022 | -6.898M |
| September 30, 2022 | -5.737M |
| June 30, 2022 | -5.351M |
| March 31, 2022 | -1.847M |
| December 31, 2021 | 4.547M |
| September 30, 2021 | 15.26M |
| June 30, 2021 | 19.86M |
| March 31, 2021 | 20.90M |
| December 31, 2020 | 13.56M |
| September 30, 2020 | -2.259M |
| June 30, 2020 | -8.014M |
| March 31, 2020 | -6.946M |
| December 31, 2019 | -6.436M |
| September 30, 2019 | -6.355M |
| June 30, 2019 | -14.25M |
| March 31, 2019 | -10.53M |
| December 31, 2018 | -10.16M |
| September 30, 2018 | -9.996M |
| June 30, 2018 | -0.339M |
| March 31, 2018 | -5.686M |
| December 31, 2017 | -6.93M |
| Date | Value |
|---|---|
| September 30, 2017 | -6.701M |
| June 30, 2017 | -7.214M |
| March 31, 2017 | -12.37M |
| December 31, 2016 | -11.65M |
| September 30, 2016 | -13.13M |
| June 30, 2016 | -13.67M |
| March 31, 2016 | -14.98M |
| December 31, 2015 | -14.54M |
| September 30, 2015 | -13.65M |
| June 30, 2015 | -14.11M |
| March 31, 2015 | -10.80M |
| December 31, 2014 | -11.70M |
| September 30, 2014 | -16.51M |
| June 30, 2014 | -16.57M |
| March 31, 2014 | -16.23M |
| December 31, 2013 | -13.82M |
| September 30, 2013 | -6.375M |
| June 30, 2013 | -3.223M |
| March 31, 2013 | 1.431M |
| December 31, 2012 | 4.665M |
| September 30, 2012 | 6.687M |
| June 30, 2012 | 7.81M |
| March 31, 2012 | 8.717M |
| December 31, 2011 | 11.22M |
| September 30, 2011 | 8.274M |
Free Cash Flow Range, Past 5 Years
-14.26M
Minimum
Dec 2023
20.90M
Maximum
Mar 2021
-1.709M
Average
-6.355M
Median
Sep 2019
Free Cash Flow Benchmarks
| Avadel Pharmaceuticals PLC | -128.51M |
| Amarin Corp PLC | 6.347M |
| DBV Technologies SA | -80.33M |
| Adaptimmune Therapeutics PLC | -145.76M |
| Akari Therapeutics PLC | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 0.242M |
| Cash from Investing (Quarterly) | -0.891M |
| Cash from Financing (Quarterly) | -1.763M |
| Free Cash Flow Per Share (Quarterly) | -0.0513 |
| Free Cash Flow to Equity (Quarterly) | -1.016M |
| Free Cash Flow to Firm (Quarterly) | 1.076M |
| Free Cash Flow Yield | -88.90% |